GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » Gross Profit

MDxHealth (MDxHealth) Gross Profit : $47.28 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is MDxHealth Gross Profit?

MDxHealth's gross profit for the three months ended in Mar. 2024 was $12.06 Mil. MDxHealth's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $47.28 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. MDxHealth's gross profit for the three months ended in Mar. 2024 was $12.06 Mil. MDxHealth's Revenue for the three months ended in Mar. 2024 was $19.83 Mil. Therefore, MDxHealth's Gross Margin % for the quarter that ended in Mar. 2024 was 60.82%.

MDxHealth had a gross margin of 60.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of MDxHealth was 74.81%. The lowest was 0.25%. And the median was 55.48%.


MDxHealth Gross Profit Historical Data

The historical data trend for MDxHealth's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth Gross Profit Chart

MDxHealth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 8.04 10.56 19.22 43.93

MDxHealth Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.72 9.99 12.55 12.67 12.06

Competitive Comparison of MDxHealth's Gross Profit

For the Diagnostics & Research subindustry, MDxHealth's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MDxHealth's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's Gross Profit distribution charts can be found below:

* The bar in red indicates where MDxHealth's Gross Profit falls into.



MDxHealth Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

MDxHealth's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=70.193 - 26.264
=43.93

MDxHealth's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=19.834 - 7.771
=12.06

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $47.28 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

MDxHealth's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=12.06 / 19.834
=60.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


MDxHealth  (NAS:MDXH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

MDxHealth had a gross margin of 60.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage


MDxHealth Gross Profit Related Terms

Thank you for viewing the detailed overview of MDxHealth's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


MDxHealth (MDxHealth) Business Description

Traded in Other Exchanges
N/A
Address
Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.